The U.S. Meals and Drug Administration (FDA) has granted orphan drug designation to DPTX3186, an investigational remedy being developed by Dewpoint Therapeutics...
On Sept. 5, 2025, the U.S. Meals and Drug Administration (FDA) accepted Inlexzo (gemcitabine intravesical system) for adults with Bacillus Calmette-Guérin (BCG)-unresponsive...
The remedy panorama for sufferers who expertise development after preliminary remedy for smooth tissue sarcomas continues to evolve, in accordance with Dr....
